Novel anti-CD38 humanized mAb SG003 possessed enhanced cytotoxicity in lymphoma than Daratumumab via antibody-dependent cell-mediated cytotoxicity

Yu, T; Qiao, CX; Lv, M; Tang, LQ

Tang, LQ (reprint author), Nanjing Med Univ, Dept Radiat Oncol, Affiliated Hosp 2, Nanjing 210011, Jiangsu, Peoples R China.

BMC BIOTECHNOLOGY, 2019; 19 ():

Abstract

Background: In vivo use of monoclonal antibodies has become routine clinical practice in the treatment of human cancer. CD38 is an attractive target, ......

Full Text Link